No increased seroprevalence of anti-Yersinia antibodies in patients with type 1 (C282Y/C282Y) hemochromatosis

Anne Jolivet-Gougeon Equipe Microbiologie, CHU Pôle Microorganismes Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, FranceCorrespondence[email protected] [email protected]

Anne Ingels Unité d'Epidémiologie Clinique et Biométrie, CHU Pontchaillou, Rennes, France

Bruno Danic Etablissement Français du Sang-Bretagne, Rennes, France

Françoise Aussant-Bertel Etablissement Français du Sang-Bretagne, Rennes, France

Claude Ferec Etablissement Français du Sang-Bretagne, Brest, France

Olivier Loréal INSERM U522, IFR 140, Université de Rennes 1, France

Jacques Minet Equipe Microbiologie, CHU Pôle Microorganismes Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, France

Pierre Brissot INSERM U522, IFR 140, Université de Rennes 1, France

show all

References

Tomaso H, Mooseder G, Dahouk SA, Bartling C, Scholz HC, Strauss R, et al. Seroprevalence of anti-Yersinia antibodies in healthy Austrians. Eur J Epidemiol 2006; 21: 77–81
PubMed Web of Science ®Google Scholar
Weinberg ED. Microbial pathogens with impaired ability to acquire host iron. Biometals 2000; 13: 85–9
PubMed Web of Science ®Google Scholar
Bottone EJ, Sheehan DJ. Yersinia enterocolitica: guidelines for serologic diagnosis of human infections. Rev Infect Dis 1983; 5: 898–906
PubMedGoogle Scholar
Sonnevend A, Czirok E, Pal T. Yersinia Yop-specific IgA antibodies in Hungarian blood donors. Folia Microbiol (Praha) 2005; 50: 269–72
PubMed Web of Science ®Google Scholar
Ibsen KK, Larsen JH. The prevalence of antibodies to hemolytic Streptococci and Yersinia enterocolitica in Danish school children and among hospitalized patients. Scand J Infect Dis 1982; 14: 277–82
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

No increased seroprevalence of anti-Yersinia antibodies in patients with type 1 (C282Y/C282Y) hemochromatosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

No increased seroprevalence of anti-Yersinia antibodies in patients with type 1 (C282Y/C282Y) hemochromatosis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date